Promoting healthcare innovation on the demand side

Area of Science:

• Health Economics
• Health Services Research
• Innovation Policy

Background:

• Traditional innovation policy incentivizes manufacturers, potentially leading to biased data on product effects and overuse of expensive technologies.
• Healthcare payers, such as insurance companies and integrated systems, possess vast datasets on patient outcomes.
• These datasets offer opportunities for independent analysis of medical treatments, bypassing costly clinical trials.

Purpose of the Study:

• To examine the role of health insurers in generating new knowledge about healthcare delivery and outcomes, termed 'demand-side innovation'.
• To explore the characteristics of firms engaged in demand-side innovation.
• To analyze the impact of existing legal frameworks on this innovation model.

Main Methods:

• Analysis of healthcare data held by payers (insurance companies, integrated healthcare providers).
• Examination of 'demand-side innovation' by healthcare payers.
• Review of legal and regulatory environments, including insurance, intellectual property, privacy, and FDA regulations.

Main Results:

• Healthcare payers can generate valuable insights into treatment effectiveness using real-world data.
• Payer involvement in innovation can counterbalance manufacturer incentives, promoting cost-effective technology use.
• Existing regulations present both opportunities and challenges for payer-driven innovation.

Conclusions:

• Demand-side innovation by healthcare payers offers a promising avenue to improve healthcare value and reduce costs.
• Policy interventions can facilitate payer innovation beyond traditional intellectual property mechanisms.
• Greater payer engagement can lead to more objective understanding and utilization of medical technologies.